These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 24444084

  • 1. A changing treatment landscape for multiple sclerosis: challenges and opportunities.
    Piehl F.
    J Intern Med; 2014 Apr; 275(4):364-81. PubMed ID: 24444084
    [Abstract] [Full Text] [Related]

  • 2. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH, Naismith RT.
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM, Carter JL.
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [Abstract] [Full Text] [Related]

  • 4. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM, Rainka MM, Patel MJ, Gengo FM.
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [Abstract] [Full Text] [Related]

  • 5. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G, Wipfler P, Ladurner G, Kraus J.
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [Abstract] [Full Text] [Related]

  • 6. [Current treatment of multiple sclerosis].
    Csépány T.
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [Abstract] [Full Text] [Related]

  • 7. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 8. [Therapy of multiple sclerosis].
    Simó M.
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    Broadley SA, Barnett MH, Boggild M, Brew BJ, Butzkueven H, Heard R, Hodgkinson S, Kermode AG, Lechner-Scott J, Macdonell RA, Marriott M, Mason DF, Parratt J, Reddel SW, Shaw CP, Slee M, Spies J, Taylor BV, Carroll WM, Kilpatrick TJ, King J, McCombe PA, Pollard JD, Willoughby E, MS Neurology Group of the Australian and New Zealand Association of Neurologists.
    J Clin Neurosci; 2014 Nov; 21(11):1847-56. PubMed ID: 24986155
    [Abstract] [Full Text] [Related]

  • 10. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S, Hohlfeld R, Voltz R.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [Abstract] [Full Text] [Related]

  • 11. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T, Bereczki D.
    Ideggyogy Sz; 2004 Nov 20; 57(11-12):401-16. PubMed ID: 15662768
    [Abstract] [Full Text] [Related]

  • 12. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ, Lublin FD, Miller AE.
    J Rehabil Res Dev; 2002 Nov 20; 39(2):273-85. PubMed ID: 12051470
    [Abstract] [Full Text] [Related]

  • 13. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B, Hartung HP.
    Ann Neurol; 2007 Oct 20; 62(4):314-26. PubMed ID: 17969020
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disease-modifying agents in multiple sclerosis.
    O'Connor PW, Oh J.
    Handb Clin Neurol; 2014 Oct 20; 122():465-501. PubMed ID: 24507532
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Rationale for an early treatment of multiple sclerosis].
    Comi G, Martino G.
    Rev Neurol; 2014 Oct 20; 30(12):1265-8. PubMed ID: 10935262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.